Abstract
Hypercholesterolemia is a major risk factor for the development and progression of cardiovascular diseases including atherosclerosis. A major active ingredient, scutellarin, from the plant Erigeron breviscapus was investigated for its hypocholesterolemic and atheroscleroprotective effects (30 and 100 mg/kg/day, p. o. ). The serum lipid profile (total cholesterol, triglycerides, high density lipoprotein cholesterol and low density lipoprotein cholesterol) was monitored and aortic functions in Sprague-Dawley rats fed with normal diet, atherogenic diet or atherogenic diet plus oral administration of either scutellarin or simvastatin (a positive control) were tested. It was found that scutellarin markedly attenuated the increased serum total cholesterol induced by atherogenic diet. It caused a significant reduction in the atherogenic index. In addition, scutellarin administration could significantly enhance acetylcholine-induced nitrate/nitrite production, increase the gene expression of endothelial nitric oxide synthase and improve acetylcholine-induced endothelium-dependent vasorelaxation in rat isolated aortas. These data revealed that scutellarin could reduce the atherogenic properties of dietary cholesterol in rats. However, whether scutellarin's atheroscleroprotective potential targets endothelial function directly or indirectly on its antioxidative activity remains to be determined.
Key words
scutellarin - atherosclerosis - hypercholesterolemia - vasorelaxation - nitric oxide - cholesterol
References
1
Prasad K, Kalra J.
Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E.
Am Heart J.
1993;
125
958-973
2 Farmer J A, Gotto A M. Dyslipidemia and other risk factors for coronary artery disease. Braunwald E Heart disease. Philadelphia; Saunders 1997: 1126-1160
3
Yan L P, Chan S W, Chan A SC, Chen S L, Ma X J, Xu H X.
Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats.
Life Sci.
2006;
79
324-330
4
Böger R H, Bode-Böger S M, Frölich J C.
The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications.
Atherosclerosis.
1996;
127
1-11
5
Kuchan M J, Frangos J A.
Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells.
Am J Physiol.
1994;
266
C628-C636
6
Rosenson R S.
Pluripotential mechanisms of cardioprotection with HMG‐CoA reductase inhibitor therapy.
Am J Cardiovasc Drugs.
2001;
1
411-420
7
Zhu B H, Guan Y Y, He H, Lin M J.
Erigeron breviscapus prevents defective endothelium-dependent relaxation in diabetic rat aorta.
Life Sci.
1999;
65
1553-1559
8
Liu H, Yang X L, Wang Y, Tang X Q, Jiang D Y, Xu H B.
Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes.
Acta Pharmacol Sin.
2003;
24
1113-1117
9
Wang L X, Zeng J P, Huang Z F, Liu Z P, Wei X B, Wang Z Y, An J, Zhang X M.
Antioxidant effect of scutellarin on PC12 cell injury induced by hydrogen peroxide in culture.
Chin J Biochem Pharm.
2005;
26
347-349
10
Ruan Z P, Yu W D.
Experimental study on anti-inflammation influence of scutellarin.
J Changzhi Med Coll.
2004;
18
88-89
11
Liu H, Yang X L, Tang R, Liu J, Xu H B.
Effect of scutellarin on nitric oxide production in early stages of neuron damage induced by hydrogen peroxide.
Pharmacol Res.
2005;
51
205-210
12
Pan Z, Feng T, Shan L, Cai B, Chu W, Niu H, Lu Y, Yang B.
Scutellarin-induced endothelium-independent relaxation in rat aorta.
Phytother Res.
2008;
22
1428-1433
13
Lin L L, Liu A J, Liu J G, Yu X H, Qin L P, Su D F.
Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats.
J Cardiovasc Pharmacol.
2007;
50
327-332
14
Hu X M, Zhou M M, Hu X M, Zeng F D.
Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion.
Acta Pharmacol Sin.
2005;
26
1454-1459
15
McCord E L, Goenka S.
Development of thyroid follicular adenoma on simvastatin therapy.
Tenn Med.
2000;
93
210-212
16
Chen W, Suruga K, Nishimura N, Gouda T, Lam V N, Yokogoshi H.
Comparative regulation of major enzymes in the bile acid biosynthesis pathway by cholesterol, cholate and taurine in mice and rats.
Life Sci.
2005;
77
746-757
17
Kannel W B.
Range of serum cholesterol values in the population developing coronary artery disease.
Am J Cardiol.
1995;
76
69C-77C
18
Sorensen K E, Celermajer D S, Georgakopoulos D, Hatcher G, Betteridge D J, Deanfield J E.
Impairment of endothelium-dependent dilation is an early event in children with familiar hypercholesterolemia and is related to the lipoprotein levels.
J Clin Invest.
1994;
93
50-55
19
Hu M Y, Li Y L, Jiang C H, Liu Z Q, Qu S L, Huang Y M.
Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
Nutrition.
2008;
24
1030-1038
20
Baylis C, Vallance P.
Measurement of nitrite and nitrate levels in plasma and urine – what does this measure tell us about the activity of the endogenous nitric oxide system?.
Curr Opin Nephrol Hypertens.
1998;
7
59-62
21
Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, Scheeren T, Gödecke A, Schrader J, Schulz R, Heusch G, Schaub G A, Bryan N S, Feelisch M, Kelm M.
Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals.
Free Radic Biol Med.
2003;
35
790-796
22
Pritchard Jr K A, Groszek L, Smalley D M, Sessa W C, Wu M, Villalon P, Wolin M S, Stemerman M B.
Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion.
Circ Res.
1995;
77
510-518
23
Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D.
Antioxidant therapy in acute central nervous system injury: current state.
Pharmacol Rev.
2002;
54
271-284
24
Jin L, Caldwell R B, Li-Masters T, Caldwell R W.
Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
J Physiol Pharmacol.
2007;
58
191-206
25
Chan S W, Li S, Kwok C Y, Benzie I FF, Szeto Y T, Guo D J, He X P, Yu P HF.
Antioxidant activity of Chinese medicinal herbs.
Pharm Biol.
2008;
46
587-595
26
Liu H, Yang X, Zhou L, Xu H.
Study on reactive oxygen species scavenging effects of scutellarin.
Zhong Yao Cai.
2002;
25
491-493
27
Förstermann U, Münzel T.
Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
Circulation.
2006;
113
1708-1714
28
Chatterjee A, Catravas J D.
Endothelial nitric oxide (NO) and its pathophysiologic regulation.
Vascul Pharmacol.
2008;
49
134-140
29
Stroes E, Hijmering M, van Zandvoort M, Wever R, Rabelink T J, van Faassen E E.
Origin of superoxide production by endothelial nitric oxide synthase.
FEBS Lett.
1998;
438
161-164
Dr. Shun-Wan Chan
Department of Applied Biology and Chemical Technology Open Laboratory of Chirotechnology The Hong Kong Polytechnic University
Hong Kong SAR
People's Republic of China
Phone: + 85 2 34 00 87 18
Fax: + 85 2 23 64 99 32
Email: bcswchan@polyu.edu.hk